These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 7580230)
21. Treatment of drug abuse syndromes. Halikas JA Psychiatr Clin North Am; 1993 Dec; 16(4):693-702. PubMed ID: 8309807 [TBL] [Abstract][Full Text] [Related]
22. Sociocultural and psychological factors in American Indian drug use: implications for treatment. Gutierres SE; Russo NF; Urbanski L Int J Addict; 1994 Dec; 29(14):1761-86. PubMed ID: 7890441 [TBL] [Abstract][Full Text] [Related]
23. [Benefits of specialized centers for the treatment of addictive disorders]. Soravia L; Allemann P Ther Umsch; 2014 Oct; 71(10):622-5. PubMed ID: 25257117 [TBL] [Abstract][Full Text] [Related]
24. Validity of the SCID in substance abuse patients. Kranzler HR; Kadden RM; Babor TF; Tennen H; Rounsaville BJ Addiction; 1996 Jun; 91(6):859-68. PubMed ID: 8696248 [TBL] [Abstract][Full Text] [Related]
25. One-year sobriety improves satisfaction with life, executive functions and psychological distress among patients with polysubstance use disorder. Hagen E; Erga AH; Hagen KP; Nesvåg SM; McKay JR; Lundervold AJ; Walderhaug E J Subst Abuse Treat; 2017 May; 76():81-87. PubMed ID: 28159440 [TBL] [Abstract][Full Text] [Related]
26. Effect of drug use and influence of abstinence on sexual functioning in a Spanish male drug-dependent sample: a multisite study. Vallejo-Medina P; Sierra JC J Sex Med; 2013 Feb; 10(2):333-41. PubMed ID: 23095213 [TBL] [Abstract][Full Text] [Related]
27. Family functioning following adolescent substance abuse treatment. Stewart MA; Brown SA J Subst Abuse; 1993; 5(4):327-39. PubMed ID: 8186668 [TBL] [Abstract][Full Text] [Related]
28. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris]. Goeb JL; Coste J; Bigot T; Ferrand I Encephale; 2000; 26(6):11-20. PubMed ID: 11217533 [TBL] [Abstract][Full Text] [Related]
29. Cognitive and behavioral dimensions of dysfunction in alcohol and polydrug abusers. Harrell TH; Honaker LM; Davis E J Subst Abuse; 1991; 3(4):415-26. PubMed ID: 1821295 [TBL] [Abstract][Full Text] [Related]
30. Predicting attrition from substance misuse treatment using the Inventory of Interpersonal Problems. Lovaglia MJ; Matano R Int J Addict; 1994 Jan; 29(1):105-13. PubMed ID: 8144264 [TBL] [Abstract][Full Text] [Related]
31. Subjective reports of withdrawal among cocaine users: recommendations for DSM-IV. Cottler LB; Shillington AM; Compton WM; Mager D; Spitznagel EL Drug Alcohol Depend; 1993 Sep; 33(2):97-104. PubMed ID: 8261885 [TBL] [Abstract][Full Text] [Related]
32. [Development and validation of an overall instrument to measure craving across multiple substances: the Mannheimer Craving Scale (MaCS)]. Nakovics H; Diehl A; Geiselhart H; Mann K Psychiatr Prax; 2009 Mar; 36(2):72-8. PubMed ID: 18924060 [TBL] [Abstract][Full Text] [Related]
33. Fitting a two-parameter logistic item response model to clarify the psychometric properties of the Drug Use Screening Inventory for adolescent alcohol and drug abusers. Kirisci L; Tarter RE; Hsu TC Alcohol Clin Exp Res; 1994 Dec; 18(6):1335-41. PubMed ID: 7695027 [TBL] [Abstract][Full Text] [Related]
34. Personality disorder features as predictors of symptoms five years post-treatment. Jansson I; Hesse M; Fridell M Am J Addict; 2008; 17(3):172-5. PubMed ID: 18463992 [TBL] [Abstract][Full Text] [Related]
35. Substance abuse and cognitive functioning in schizophrenia. Addington J; Addington D J Psychiatry Neurosci; 1997 Mar; 22(2):99-104. PubMed ID: 9074303 [TBL] [Abstract][Full Text] [Related]
36. Predicting relapse and recovery in alcoholism and addiction: neuropsychology, personality, and cognitive style. Miller L J Subst Abuse Treat; 1991; 8(4):277-91. PubMed ID: 1664867 [TBL] [Abstract][Full Text] [Related]
38. Impact of pregnancy on psychoactive substance use among women with substance use disorders recruited in addiction specialized care centers in France. Pochard L; Dupouy J; Frauger E; Giocanti A; Micallef J; Lapeyre-Mestre M; Fundam Clin Pharmacol; 2018 Apr; 32(2):188-197. PubMed ID: 29337399 [TBL] [Abstract][Full Text] [Related]
39. The relationship between length of stay in drug-free therapeutic communities and neurocognitive functioning. Fals-Stewart W; Schafer J J Clin Psychol; 1992 Jul; 48(4):539-43. PubMed ID: 1325478 [TBL] [Abstract][Full Text] [Related]
40. The development and reliability of the RAATE-CE. Smith MB; Hoffmann NG; Nederhoed R J Subst Abuse; 1992; 4(4):355-63. PubMed ID: 1294278 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]